These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 11659537

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J, Levine RJ.
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract] [Full Text] [Related]

  • 3. IRBs and pharmaceutical company funding of research.
    Jellinek MS, Levine RJ.
    IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
    [No Abstract] [Full Text] [Related]

  • 4. Policies and quality assurance in the pharmaceutical industry.
    Shamoo AE.
    Account Res; 1991 Oct; 1(4):273-84. PubMed ID: 11651459
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role and responsibility of industry in research.
    Lasagna L.
    Dolentium Hominum; 1987 Oct; 4(2nd Yr. 1):56-9. PubMed ID: 11653199
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM.
    J Coll Univ Law; 1988 Oct; 15(2):185-216. PubMed ID: 11659168
    [No Abstract] [Full Text] [Related]

  • 9. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized.
    Siris ES, Burrell CD.
    IRB; 1983 Oct; 5(6):1-5. PubMed ID: 11649526
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reviewing subject recruitment: new rules from Rockville.
    McMahon FG.
    IRB; 1988 Oct; 10(3):6-7. PubMed ID: 11651911
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.
    Gordon VM, Sugarman J, Kass N.
    IRB; 1998 Oct; 20(1):1-5. PubMed ID: 11655324
    [No Abstract] [Full Text] [Related]

  • 15. Money is putting people at risk in biomedical research.
    Andrews LB.
    Chron High Educ; 2000 Mar 10; 46(27):B1, B4-5. PubMed ID: 11657699
    [No Abstract] [Full Text] [Related]

  • 16. In business to treat cancer.
    Henig RM.
    N Y Times Mag; 1986 Nov 23; ():68, 70, 78, 80+. PubMed ID: 11647805
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Federal agency revises rule on financial disclosure by researchers.
    Maloney DM.
    Hum Res Rep; 1999 Feb 23; 14(2):1-2. PubMed ID: 11657602
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.